Krystal Biotech, Inc.
KRYS
Classement en actions
#2125
Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on... Krystal Biotech, Inc. is a clinical-stage biotechnology company focused on developing redosable gene therapies to address severe orphan diseases across the United States. Its most advanced therapeutic candidate, beremagene geperpavec (B-VEC), is currently undergoing Phase III clinical evaluation for the treatment of dystrophic epidermolysis bullosa. The company's pipeline also includes several other promising programs: KB105 is in Phase I/II clinical trials for patients suffering from deficient autosomal recessive congenital ichthyosis; KB301 is also in Phase I/II development, aiming to ameliorate wrinkles and other signs of aging or damaged skin. Additionally, Krystal Biotech is conducting preclinical research on KB407 for cystic fibrosis and KB104 for Netherton syndrome. In its earlier discovery phase, the company is exploring candidates such as KB5xx for chronic skin conditions and multiple KB3xx programs targeting aesthetic dermatological concerns. Krystal Biotech, Inc. was established in 2015 and is based in Pittsburgh, Pennsylvania.
Prix de l'action
$326.41
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$9.66B
Changement (1 jour)
1.92%
Changement (1 an)
71.09%
Pays
US
Échange Krystal Biotech, Inc. (KRYS)
Catégorie
Healthcare
Nombre d'actions en circulation pour Krystal Biotech, Inc. (KRYS)
Nombre d'actions en circulation au June 2026: 29.53M
Selon les derniers rapports financiers et le cours de l'action de Krystal Biotech, Inc., le nombre actuel d'actions en circulation est de 29.53M. À la fin de December 2023, l'entreprise avait 27.15M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Krystal Biotech, Inc. (KRYS) de 2016 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 29.53M | 3.28% |
| 2024 | 28.59M | 5.30% |
| 2023 | 27.15M | 6.52% |
| 2022 | 25.49M | 14.85% |
| 2021 | 22.20M | 18.15% |
| 2020 | 18.79M | 18.15% |
| 2019 | 15.90M | 41.93% |
| 2018 | 11.20M | 108.99% |
| 2017 | 5.36M | 25.38% |
| 2016 | 4.28M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 253.90M | 759.83% |
US
|
|
| 396.00M | 1,241.05% |
US
|
|
| 478.91M | 1,521.84% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 110.59% |
NL
|
